A new report released on Monday found no clear evidence linking paracetamol use during pregnancy to autism in children.
The finding comes from a comprehensive review of existing studies published in the British medical journal BMJ by a team of UK-led researchers.
This update follows a clarification from the World Health Organisation (WHO) just two months ago, stating that there is currently no conclusive scientific evidence connecting acetaminophen—commonly known as paracetamol—taken during pregnancy to autism.
The WHO’s statement was issued in response to claims by US President Donald Trump suggesting a link between childhood vaccines, paracetamol use by pregnant women, and autism.
However, in their review, the researchers concluded that current scientific evidence does not support any connection between autism and the use of paracetamol during pregnancy.
“Existing evidence does not show a clear link between in utero exposure to paracetamol and autism and ADHD in offspring,” the team wrote.
The WHO had previously noted, “Extensive research has been undertaken over the past decade, including large-scale studies, looking into links between acetaminophen use during pregnancy and autism. At this time, no consistent association has been established.”
The global health body encouraged pregnant women to continue following the guidance of their healthcare providers.
“WHO recommends that all women continue to follow the advice of their doctors or health workers, who can help assess individual circumstances and recommend necessary medicines.
“Any medicine should be used with caution during pregnancy, especially in the first three months, and in line with advice from health professionals,” the statement added.
